Does tralokinumab have a higher rate of conjunctivitis versus dupilumab?

Featuring Tina Bhutani, MD, MAS | CEO, Synergy Dermatology Associate Clinical Professor of Dermatology University of California, SF San Francisco, CA | Published February 16, 2023